We also excluded cases with cytokine autoantibodies targeting type 1 interferons α and ω, as well as IL-22, typical of recessive APS1 and also present in some cases with dominant APS134,52–55. This evidence concerns the gene IL22 and Autoimmune polyendocrinopathy type 1.